Le Lézard
Classified in: Health
Subjects: LAW, PLW

SchureMed Announces Settlement with Allen Medical


ABINGTON, Mass., March 17, 2021 /PRNewswire/ -- Schuerch Corporation (d/b/a SchureMed) announced today the conclusion of a dispute with Allen Medical Systems, Inc., a Hillrom (NYSE: HRC) company, pending in federal district court in Massachusetts (Case No. 1:15-cv-13024), following a recent ruling in Allen Medical's favor. The companies have entered into a consent judgment requiring SchureMed to make certain payments and refrain from further infringing conduct.

Allen Medical brought the lawsuit in 2015 alleging that SchureMed infringed two Allen Medical patents on revolutionary surgical-table stirrups and surgical-table clamps (U.S. Patent Nos. RE41,412 and 6,622,980). The court issued an order rejecting SchureMed's interpretation and accepting the arguments of Allen Medical as to both patents on June 26, 2020, and the case was set to proceed with expert witnesses and trial on the issues of damages and infringement. SchureMed stopped selling the associated products during the litigation.

Under the terms of the consent judgment, SchureMed agreed not to sell any product that would infringe the ?980 patent, the ?412 patent having expired during the litigation). SchureMed is further obligated to make payments reimbursing Allen Medical for lost sales during the time period that SchureMed was selling the products that Allen Medical had accused of infringing the patents.

"At Hillrom we prize and vigorously protect our intellectual property," said Amy Dodrill, president of Hillrom's Surgical Solutions business. "We are pleased to conclude this case, and that SchureMed will compensate Allen Medical for its losses."

"SchureMed is happy to have resolved the issue," said SchureMed's Peter Schuerch. "Hillrom is an important customer of SchureMed, and SchureMed seeks to maintain that relationship."

CONTACT: Monica Pena, 781-982-7000, [email protected]

SOURCE SchureMed


These press releases may also interest you

at 10:45
eBlu Solutions, a leading provider of innovative technology solutions for the specialty healthcare industry, is pleased to announce the addition of Doug Lawrence to the Executive Leadership team in the role of Chief Revenue Officer. "We're not just...

at 09:18
NUVISTA Mental Health proudly announces its participation as a Gold Sponsor for the 2024 Ontario First...

at 09:05
Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL?HF,...

at 06:05
Dr. Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research Centre (KFSH&RC) joined the Gulf Creatives Conference (GCC) at Harvard 2024. The event, GCC at Harvard, is organized by The Diwan, an organization run by graduate students at...

at 06:00
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use across a range of infectious disease, oncology,...

at 03:14
Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention on Wednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in...



News published on and distributed by: